171 related articles for article (PubMed ID: 37796681)
21. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma.
Gong M; Feng S; Zhou D; Luo J; Lin T; Qiu S; Yuan R; Dong W
Eur J Med Res; 2023 Oct; 28(1):440. PubMed ID: 37848987
[TBL] [Abstract][Full Text] [Related]
23. Predictive values of Notch signalling in renal carcinoma.
Jędroszka D; Orzechowska M; Bednarek AK
Arch Med Sci; 2017 Oct; 13(6):1249-1254. PubMed ID: 29181054
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of glutathione peroxidase-1 (GPX1) expression and prognostic value in three different types of renal cell carcinoma.
Chen S; Su X; Mi H; Dai X; Li S; Chen S; Zhang S
Transl Androl Urol; 2020 Dec; 9(6):2737-2750. PubMed ID: 33457246
[TBL] [Abstract][Full Text] [Related]
25. Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma.
Zhou X; Huang H; Cui W; Wang Y; Luo W; Matskova L; Zhou X
Med Sci Monit; 2020 Jun; 26():e922836. PubMed ID: 32511216
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
27. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z
Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856
[TBL] [Abstract][Full Text] [Related]
28. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of ACAT1 promotes epithelial-mesenchymal transition of clear cell renal cell carcinoma.
Han P; Wu S; Li L; Li D; Zhao J; Zhang H; Wang Y; Zhong X; Zhang Z; Li P; Matskova L; Zhou X
Genes Genomics; 2022 Apr; 44(4):487-497. PubMed ID: 34985712
[TBL] [Abstract][Full Text] [Related]
30. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
[TBL] [Abstract][Full Text] [Related]
31. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization.
Hebbring SJ; Chai Y; Ji Y; Abo RP; Jenkins GD; Fridley B; Zhang J; Eckloff BW; Wieben ED; Weinshilboum RM
J Neurochem; 2012 Mar; 120(6):881-90. PubMed ID: 22220685
[TBL] [Abstract][Full Text] [Related]
32. SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis.
Anderson DD; Stover PJ
PLoS One; 2009 Jun; 4(6):e5839. PubMed ID: 19513116
[TBL] [Abstract][Full Text] [Related]
33. The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism.
Guiducci G; Paone A; Tramonti A; Giardina G; Rinaldo S; Bouzidi A; Magnifico MC; Marani M; Menendez JA; Fatica A; Macone A; Armaos A; Tartaglia GG; Contestabile R; Paiardini A; Cutruzzolà F
Nucleic Acids Res; 2019 May; 47(8):4240-4254. PubMed ID: 30809670
[TBL] [Abstract][Full Text] [Related]
34. Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes.
Caliskan A; Andac AC; Arga KY
Genomics; 2020 Sep; 112(5):3166-3178. PubMed ID: 32512143
[TBL] [Abstract][Full Text] [Related]
35. The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma.
Ahmadi M; Najari-Hanjani P; Ghaffarnia R; Ghaderian SMH; Mousavi P; Ghafouri-Fard S
Pathol Res Pract; 2023 Nov; 251():154903. PubMed ID: 37879147
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal papillary cell carcinoma.
Yao ZY; Xing CQ; Zhang T; Liu YW; Xing XL
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2235-2244. PubMed ID: 33755961
[TBL] [Abstract][Full Text] [Related]
37. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
[TBL] [Abstract][Full Text] [Related]
38. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
39. Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined
Malik M; Maqbool M; Nisar T; Akhter T; Ujan JA; Algarni AS; Joufi FAA; Alanazi SSK; Almotared MH; Bekhit MMS; Jamil M
Oncol Res; 2023; 31(6):899-916. PubMed ID: 37744271
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]